Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Sirenicapillaria stauglerae strain:BLCC-M123

ABSTRACT: Sirenicapillaria stauglerae strain:BLCC-M123 Genome sequencing

PROVIDER: PRJNA874164 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Similar Datasets

Johannesbaptistia floridana strain:BLCC-M67

Project description:Johannesbaptistia floridana strain:BLCC-M67 Genome sequencing

| PRJNA826087 | ENA

Fistulifera alcalina strain:BLCC-F88

Project description:Fistulifera alcalina strain:BLCC-F88 Genome sequencing and assembly

| PRJNA722730 | ENA

Microcystis aeruginosa BLCC-F158 strain:BLCCF158

Project description:Microcystis aeruginosa BLCC-F158 strain:BLCCF158 Genome sequencing and assembly

| PRJNA647120 | ENA

Iningainema tapete BLCC-T55 strain:BLCCT55

Project description:Iningainema tapete BLCC-T55 strain:BLCCT55 Genome sequencing and assembly

| PRJNA662357 | ENA

Spirulinales cyanobacterium BLCC-M108

Project description:Spirulinales cyanobacterium BLCC-M108 Genome sequencing

| PRJNA945415 | ENA

Roseofilum acuticapitatum BLCC-M154

Project description:Roseofilum acuticapitatum BLCC-M154 Genome sequencing and assembly

| PRJNA926904 | ENA

Roseofilum capinflatum BLCC-M114

Project description:Roseofilum capinflatum BLCC-M114 Genome sequencing and assembly

| PRJNA926903 | ENA

Roseofilum casamattae BLCC-M143

Project description:Roseofilum casamattae BLCC-M143 Genome sequencing and assembly

| PRJNA926908 | ENA

Roseofilum halophilum BLCC-M91

Project description:Roseofilum halophilum BLCC-M91 Genome sequencing and assembly

| PRJNA925516 | ENA

Treatment of Venous Leg Ulcers with a Bioengineered Living Cell Construct Reactivates the Acute Wound Healing Response

Project description:Chronic non-healing venous leg ulcers (VLUs) are a widespread debilitating disease with high morbidity and associated costs, as approximately $15 billion annually are spent on the care of VLUs. Despite their socioeconomic burden, there is a paucity of novel treatments targeted towards healing VLUs, which can be attributed to both lack of pathophysiologic insight into VLU development as well as lack of knowledge regarding biologic actions of VLU-targeted therapies. Currently, the bioengineered bilayered living cellular construct (BLCC) skin substitute is the only FDA-approved biologic treatment for healing VLUs. To elucidate the mechanisms through which the BLCC promotes healing of chronic VLUs, we conducted a clinical trial (NCT01327937) in which patients with non-healing VLUs were treated with either standard care (compression therapy) or with BLCC together with standard care. Tissue was collected from the VLU edge before and 1 week after treatment, and samples underwent comprehensive microarray, mRNA and protein analyses. Ulcers treated with BLCC skin substitute displayed three distinct patterns suggesting the mechanisms by which BLCC shifted a non-healing into a healing tissue response: it modulated inflammatory and growth factor signaling; it activated keratinocytes; and it attenuated Wnt/β-catenin signaling. In these ways, BLCC application orchestrated a shift of the chronic non-healing ulcer microenvironment into a distinctive healing milieu resembling that of an acute, healing wound. Our findings also provide first patient-derived in vivo evidence of specific biologic processes that can be targeted in the design of therapies to promote healing of chronic VLUs.

2016-09-01 | GSE84571 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data